Azulfidine en-tabs and Oedema - a phase IV clinical study of FDA data

Summary:

Oedema is reported as a side effect among people who take Azulfidine en-tabs (sulfasalazine), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Prednisolone, and have Short-bowel syndrome.

The phase IV clinical study analyzes which people have Oedema when taking Azulfidine en-tabs. It is created by eHealthMe based on reports of 2,198 people who have side effects when taking Azulfidine en-tabs from the FDA, and is updated regularly.

What is Azulfidine en-tabs?

Azulfidine en-tabs has active ingredients of sulfasalazine. It is often used in rheumatoid arthritis. eHealthMe is studying from 2,220 Azulfidine en-tabs users. Check the latest studies of Azulfidine en-tabs.

What is Oedema?

Oedema (fluid collection in tissue) is found to be associated with 2,211 drugs and 2,311 conditions by eHealthMe. Check the latest studies of Oedema.

On Jul, 16, 2026

2,198 people reported to have side effects when taking Azulfidine en-tabs.
Among them, 25 people (1.14%) have Oedema.

Among these 25 people:

How long have people been on Azulfidine en-tabs when they have Oedema? *

What is the gender of people who have Oedema when taking Azulfidine en-tabs? *

female: 70.83 %
male: 29.17 %

What is the age of people who have Oedema when taking Azulfidine en-tabs? *

What are other drugs people take besides Azulfidine en-tabs? *

What are other side effects people have besides Oedema? *

Fever: 7 people, 28.00%
Joint Pain: 7 people, 28.00%
Abdominal Distension: 5 people, 20.00%
Itching: 4 people, 16.00%
Liver Function Tests Nos Abnormal: 4 people, 16.00%
Rashes (redness): 3 people, 12.00%
Dyspnea (difficult or laboured breathing): 3 people, 12.00%
Pleural Effusion (water on the lungs): 3 people, 12.00%
Face Oedema (swelling of face): 3 people, 12.00%
Fall: 3 people, 12.00%

What are the existing conditions these people have? *

Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 4 people, 16.00%
Right Ventricular Failure (right half of the heart fails to work): 3 people, 12.00%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 12.00%
Osteoporosis (bones weak and more likely to break): 3 people, 12.00%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 12.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 12.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 12.00%
Iron Deficiency Anaemia: 2 people, 8.00%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 4.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Azulfidine en-tabs and have Oedema?

- Check whether Oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azulfidine en-tabs:

Azulfidine en-tabs (2,220 reports)

Oedema treatments and more:

Oedema (78,747 reports)

Browse all side effects of Azulfidine en-tabs:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oedema:

Oedema (2,211 drugs)

Browse all the conditions that are associated with Oedema:

Oedema (2,311 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sulfasalazine (the active ingredients of Azulfidine en-tabs) and Azulfidine en-tabs (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.